Related Experiment Videos
Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies
M J O'Doherty1, A G Kettle, P Wells
1Department of Nuclear Medicine, Kent and Canterbury Hospital, United Kingdom.
Summary
Technetium-99m-sestamibi demonstrates comparable effectiveness to thallium-201 for parathyroid imaging. This new agent offers potential advantages due to superior physical characteristics and a higher target-to-background ratio.
Area of Science:
- Nuclear Medicine
- Radiopharmacology
- Endocrine Surgery
Background:
- The established method for parathyroid imaging involves combining [99mTc]pertechnetate and 201Tl-chloride.
- Limitations of the current approach necessitate the development of superior parathyroid imaging agents.
Purpose of the Study:
- To evaluate the efficacy of 99mTc-sestamibi as a parathyroid imaging agent.
- To compare the performance of 99mTc-sestamibi directly against 201Tl-chloride.
Main Methods:
- Preoperative imaging of 57 patients using both 99mTc-sestamibi and 201Tl.
- Assessment of tissue uptake differences by administering 10 MBq of each agent to 20 patients undergoing surgery.
- Histopathological analysis of biopsied tissues.
Main Results:
- 99mTc-sestamibi localized 39 out of 40 adenomas, while 201Tl localized 37.
- 99mTc-sestamibi localized 32 out of 29 hyperplastic glands, compared to 29 with 201Tl.
- While 201Tl showed higher overall uptake in parathyroid and thyroid tissue, sestamibi exhibited a higher uptake per gram in parathyroid tissue relative to thyroid tissue.
Conclusions:
- Technetium-99m-sestamibi is at least as effective as 201Tl-chloride for parathyroid localization.
- Improved target-to-background ratios and the superior physical properties of 99mTc contribute to sestamibi's efficacy.